Compare HCA Health Inc (HCA) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Immunovant Inc. Common Stock — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: HCA Health Inc is far larger — about 14.4× Immunovant Inc. Common Stock's market cap, and HCA Health Inc pays a 0.71% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Immunovant Inc. Common Stock for 0 Days on average.
| HCA | IMVT | |
|---|---|---|
Market Cap | $95.08B | $6.62B |
Volume | 998,787 | 1,131,364 |
Sector | Health | Health |
52-Week High | $545.13 | $44.96 |
52-Week Low | $361.32 | $17.03 |
Typical Hold Time | 76 Days | 0 Days |
Enterprise Value | $145.62B | $5.72B |
Dividend Yield | 0.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
